GlaxoSmithKline plc logo Capital Fund Management S.A. purchased a new stake in shares of GlaxoSmithKline plc (NYSE:GSK) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).
I don't know about you, but I for one am glad to see the back of January. Despite my personal portfolio's small-cap growth-oriented construction, I've been along for the ride on the turbulent market roller coaster.
GlaxoSmithKline plc logo GlaxoSmithKline plc (NYSE:GSK) had its target price upped by Sanford C. Bernstein from $43.00 to $45.00 in a research report report published on Thursday morning, StockTargetPrices.
Despite the sterling work achieved by its R&D department over the past year, drugs giant GlaxoSmithKline (LSE: GSK) is still struggling to overcome insipid investor appetite. Shares in the firm have tracked 15% lower from last April's peaks of around ...